Make Your Voice Heard
Three Reasons the Administration Should Abandon its International Pricing Index Proposal
IPI Model Could Severely Limit Access to Medicines For America’s Patients
IPI Model Will Greatly Impact R&D Of New Medicines
Stop Washington from Imposing Flawed Pricing Schemes
The Pharmaceutical Research and Manufacturers of America, PhRMA, represents the country’s leading biopharmaceutical researchers and biotechnology companies.
latest from the
Blog
88%
decline in hiv/aids death rates
Since the 1990s
80%
of 340B volume goes through DSH hospitals even though they make up just 9% of 340B entities.
$2.6
billion
The average cost to develop one new medicine.
8
months
Priority FDA review time thanks to PDUFA
80+
autoimmune diseases
have been identified to-date
7,000
new medicines
Currently in development around the world.
